Antibodies, Antiphospholipid

• 

  Subject Areas on Research

  • 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. 
  • 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. 
  • 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. 
  • Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodies. 
  • Anatomic distribution of venous thrombosis in patients with antiphospholipid antibody: imaging findings. 
  • Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I. 
  • Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? 
  • Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines. 
  • Antiphospholipid Syndrome Clinical Research Task Force report. 
  • Antiphospholipid antibodies after surgical exposure to topical bovine thrombin. 
  • Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa. 
  • Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. 
  • Antiphospholipid antibodies in pediatric lupus nephritis. 
  • Antiphospholipid antibodies. 
  • Antiphospholipid antibodies: findings at arteriography. 
  • Aspirin and reproductive outcomes. 
  • Assessment of the 2006 revised antiphospholipid syndrome classification criteria. 
  • Catastrophic antiphospholipid syndrome after cardiac surgery. 
  • Clinical utility of antiphospholipid antibodies? A negative study with power! 
  • Clinical utility of antiphospholipid antibodies? A negative study with power! 
  • Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. 
  • Diagnosis of pulmonary embolism. 
  • Dural sinus thrombosis and venous infarction associated with antiphospholipid antibodies: MR findings. 
  • From antiphospholipid syndrome to antibody-mediated thrombosis. 
  • Gene-expression patterns predict phenotypes of immune-mediated thrombosis. 
  • Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. 
  • Laboratory criteria for antiphospholipid syndrome: reply. 
  • Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis? 
  • Patients with antiphospholipid antibodies: CT and MR findings of the brain. 
  • Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies. 
  • Polypoidal choroidal vasculopathy and systemic lupus erythematosus. 
  • Prothrombin and beta 2-glycoprotein I frequently contribute to antiphospholipid antibody interactions with phospholipids and the generation of abnormal waveform profiles in coagulation assays. 
  • Risk factors associated with thrombosis in patients with antiphospholipid antibodies. 
  • Subdural hematoma and lupus anticoagulants. 
  • Systemic thrombosis in patients with antiphospholipid antibodies: lesion distribution and imaging findings. 
  • Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH. 
  • The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it? 
  • Thoracic imaging features of patients with antiphospholipid antibodies. 
• 

  Keywords of People

  • Hoffman, Maureane, Professor of Pathology, Immunology
  • Schanberg, Laura Eve, Professor of Pediatrics, Pediatrics, Rheumatology